Patents/Assignees

ABELZETA Inc.

8 patents in portfolio

US12583903utility2026
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
0 cites
US12577541utility2026
Method for Large-scale Preparation of Purified Preparation of Recombinant Lentiviral Vector at GMP Grade
0 cites
US12458667utility2025
Bispecific Chimeric Antigen Receptors Targeting CD20 and BCMA
0 cites
US12448432utility2025
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Application Thereof
0 cites
US12356981utility2025
Cell Freezing Medium for Clinical Use
0 cites
US12338494utility2025
Reagent and Method for Fluorescence Quantitative Real-time PCR Detection of RCL
0 cites
US12311022utility2025
Bispecific Chimeric Antigen Receptors Targeting CD20 and BCMA
0 cites
US12018293utility2024
Method for Large-scale Preparation of Purified Preparation of Recombinant Lentiviral Vector at GMP Grade
0 cites